The impact of age on changes in quality of life among breast cancer survivors treated with breast-conserving surgery and radiotherapy

Background: The purpose of the study was to determine the impact of young age on health-related quality of life (HRQoL) by comparing HRQoL of younger and older breast cancer patients, corrected for confounding, and of young patients and a general Dutch population. Methods: The population consisted o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:British journal of cancer Ročník 112; číslo 4; s. 636 - 643
Hlavní autoři: Bantema-Joppe, E J, de Bock, G H, Woltman-van Iersel, M, Busz, D M, Ranchor, A V, Langendijk, J A, Maduro, J H, van den Heuvel, E R
Médium: Journal Article
Jazyk:angličtina
Vydáno: London Nature Publishing Group UK 17.02.2015
Nature Publishing Group
Témata:
692/699/67/1059/485
692/699/67/1347
692/700/565/545/546
692/700/784
Adult
Age Factors
Aged
Aged, 80 and over
Biomedicine
Breast Neoplasms - mortality
Breast Neoplasms - radiotherapy
Breast Neoplasms - surgery
Cancer Research
Clinical Study
Cohort Studies
Drug Resistance
Epidemiology
Female
Health Status
Humans
Mastectomy, Segmental
Middle Aged
Molecular Medicine
Oncology
Quality of Life
Surveys and Questionnaires
Survivors - psychology
Netherlands
radiotherapy
breast cancer
health-related quality of life
breast-conserving therapy
young
ISSN:0007-0920, 1532-1827, 1532-1827
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Background: The purpose of the study was to determine the impact of young age on health-related quality of life (HRQoL) by comparing HRQoL of younger and older breast cancer patients, corrected for confounding, and of young patients and a general Dutch population. Methods: The population consisted of breast cancer survivors (stage 0-III) after breast-conserving surgery and radiotherapy. Health-related quality of life was prospectively assessed using the EORTC QLQ-C30 and QLQ-BR23 questionnaires. The association between age (⩽50; 51–70; ⩾70 years) and HRQoL over time was analysed with mixed modelling. The clinical relevance of differences between/within age groups was estimated with Cohen’s D and consensus-based guidelines. The HRQoL data from the young patient cohort were compared with Dutch reference data at 3 years after radiotherapy. Results: A total of 1420 patients completed 3200 questionnaires. Median follow-up was 34 (range 6–70) months. Median age was 59 (range 28–85) years. Compared with older subjects, young women reported worse HRQoL in the first year after radiotherapy, but clinical relevance was limited. Three years after radiotherapy, HRQoL values in the younger group were equal to those in the reference population. Pain and fatigue after radiotherapy improved, with medium clinical relevance. Conclusions: Three years after radiotherapy for breast cancer, young age was not a risk factor for decreased HRQoL.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0007-0920
1532-1827
1532-1827
DOI:10.1038/bjc.2014.632